Leon G Leanse1,2, Pu-Ting Dong3, Xueping S Goh1,2, Min Lu1, Ji-Xin Cheng3,4, David C Hooper5, Tianhong Dai1,2. 1. Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. 2. Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. 3. Department of Chemistry, Boston University, Boston, Massachusetts, USA. 4. Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA. 5. Division of Infectious Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Antimicrobial resistance is a significant concern to public health, and there is a pressing need to develop novel antimicrobial therapeutic modalities. METHODS: In this study, we investigated the capacity for quinine hydrochloride (Q-HCL) to enhance the antimicrobial effects of antimicrobial blue light ([aBL] 405 nm wavelength) against multidrug-resistant (MDR) Gram-negative bacteria in vitro and in vivo. RESULTS: Our findings demonstrated the significant improvement in the inactivation of MDR Pseudomonas aeruginosa and Acinetobacter baumannii (planktonic cells and biofilms) when aBL was illuminated during Q-HCL exposure. Furthermore, the addition of Q-HCL significantly potentiated the antimicrobial effects of aBL in a mouse skin abrasion infection model. In addition, combined exposure of aBL and Q-HCL did not result in any significant apoptosis when exposed to uninfected mouse skin. CONCLUSIONS: In conclusion, aBL in combination with Q-HCL may offer a novel approach for the treatment of infections caused by MDR bacteria.
BACKGROUND: Antimicrobial resistance is a significant concern to public health, and there is a pressing need to develop novel antimicrobial therapeutic modalities. METHODS: In this study, we investigated the capacity for quinine hydrochloride (Q-HCL) to enhance the antimicrobial effects of antimicrobial blue light ([aBL] 405 nm wavelength) against multidrug-resistant (MDR) Gram-negative bacteria in vitro and in vivo. RESULTS: Our findings demonstrated the significant improvement in the inactivation of MDR Pseudomonas aeruginosa and Acinetobacter baumannii (planktonic cells and biofilms) when aBL was illuminated during Q-HCL exposure. Furthermore, the addition of Q-HCL significantly potentiated the antimicrobial effects of aBL in a mouseskin abrasion infection model. In addition, combined exposure of aBL and Q-HCL did not result in any significant apoptosis when exposed to uninfected mouse skin. CONCLUSIONS: In conclusion, aBL in combination with Q-HCL may offer a novel approach for the treatment of infections caused by MDR bacteria.
Authors: Yucheng Wang; Ying Wang; Yuguang Wang; Clinton K Murray; Michael R Hamblin; David C Hooper; Tianhong Dai Journal: Drug Resist Updat Date: 2017-10-13 Impact factor: 18.500
Authors: John N Alumasa; Alexander P Gorka; Leah B Casabianca; Erica Comstock; Angel C de Dios; Paul D Roepe Journal: J Inorg Biochem Date: 2010-09-22 Impact factor: 4.155
Authors: Jane Achan; Ambrose O Talisuna; Annette Erhart; Adoke Yeka; James K Tibenderana; Frederick N Baliraine; Philip J Rosenthal; Umberto D'Alessandro Journal: Malar J Date: 2011-05-24 Impact factor: 2.979
Authors: Jacob E Choby; Caroline M Grunenwald; Arianna I Celis; Svetlana Y Gerdes; Jennifer L DuBois; Eric P Skaar Journal: MBio Date: 2018-02-06 Impact factor: 7.867
Authors: Leon G Leanse; Carolina Dos Anjos; Ying Wang; Clinton K Murray; David C Hooper; Tianhong Dai Journal: J Infect Dis Date: 2021-09-17 Impact factor: 5.226
Authors: Mengjie Wu; Andrey Ethan Rubin; Tianhong Dai; Rene Schloss; Osman Berk Usta; Alexander Golberg; Martin Yarmush Journal: Adv Wound Care (New Rochelle) Date: 2020-12-18 Impact factor: 4.947
Authors: Carolina Dos Anjos; Leon G Leanse; Xiaojing Liu; Hugo V Miranda; R Rox Anderson; Tianhong Dai Journal: Front Microbiol Date: 2022-07-12 Impact factor: 6.064